We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Polarean Imaging Plc | LSE:POLX | London | Ordinary Share | GB00BF3DT583 | ORD GBP0.00037 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -2.56% | 3.80 | 3.70 | 3.90 | 3.90 | 3.80 | 3.90 | 161,416 | 14:57:33 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 1.03M | -13.91M | -0.0644 | -0.59 | 8.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/6/2019 09:03 | nice to meet a friend Yes a lot of upside and still under the radar | wisecat2 | |
27/6/2019 08:22 | Heading towards 25p I reckon | rakepat37 | |
27/6/2019 08:15 | Exciting times here we could seriously re rate into the 40p plus ... one we get approval then skys the limit .... half a billion pound company in the making | rakepat37 | |
23/1/2019 11:22 | Looking for a pulse | wisecat2 | |
10/4/2018 11:58 | Don't know why you think this is only applicable to research. At the moment it hasn't got regulatory approval so is limited to research on a case by case basis, but diagnostic equipment is critical in helping physicians diagnose early and determining treatments for patients, and from my understanding of this technology, this will be very useful and a good use of money. As a shareholder in Amphion, I see the IPO market cap was £11m, which was half the original 'estimate'/target, but you always aim high. It's only on Dragons Den that entrepreneurs come in valuing their own company at £800,000 and the Dragons revalue it at £12.5m! In my view | gclark | |
05/4/2018 08:21 | I looked at buying a few in the IPO but decided against it (even with the EIS tax breaks). Their product looks like a "nice to have" research tool, but when it comes to prioritizing healthcare budgets, it is never likely to be at the front of the queue. | timbo003 | |
29/3/2018 12:55 | !FOLLOWFEED | andrbea |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions